Background
Methods
Eligibility criteria
Types of studies
Population
Outcomes
Search strategy and information sources
Data collection and analysis
Study selection
Data extraction
Study | Population | Nocturia Assessment | Cognitive dysfunction Assessment |
---|---|---|---|
Dutoglu et al. (2019) [17] | 858 outpatients admitted to a geriatric center Female: 100% Mean (sd) age: 74.1 (8.2) years | “Generally, during the past 30 days, how many times do you usually urinate after you have gone to sleep at night until the time you got up in the morning?” Cut-off: 1, 2, 3, 4 or more Prevalence: 19.0, 24.2, 18.4, and 24.1% respectively | MMSE and Dementia diagnosed using the DSM V Mean (sd) MMSE score: 24.7 (4.9), 25.0 (4.2), 24.9 (3.7), 24.2 (4.4), 23.9 (4.9) in patients with 0, 1, 2, 3 or ≥ 4 nocturia episodes respectively Prevalence (dementia): 4.4% |
Jung et al. (2017) [11] | 376 patients with probable Alzheimer’s disease Female: 51.1% Age range: 56–92 years | OABSS Mean (sd) number of nocturia episodes: 1.2 (0.8), 1.2 (0.9) and 1.6 (1.0) in patients with OABSS ≤5, 6–11 or ≥ 12 respectively Prevalence: NR | MMSE and CDR scale Mean (sd) MMSE score: 14.4 (7.6) in patients with OAB Mean (sd) CDR score: 2.3 (0.9) in patients with OAB |
Zhang et al. (2016) [18] | 454 patients with Parkinson’s disease Female: 42.7% Mean (sd) age: 61.5 (10.9) years | NMSS Mean (sd) NMSS score for nocturia: 2.4 (3.3) Cut-off: NR Prevalence: 47.2% | MoCA Mean (sd) MoCA score: 23.7 (4.5) Prevalence (MoCA ≤25): 58.1% |
Scullin et al. (2013) [19] | 143 patients with Parkinson’s disease Female: 35% Mean (sd) age: 64.7 (9.0) years | “When you awaken during the night, how often do you urinate?” on sleep questionnaire drawn from existing studies; Nocturia frequency evaluated on 4-point Likert scale (1 = “never,” 4 = “very often”) Prevalence: NR | Impulsivity determined by at least 1 “yes” to the Minnesota Impulse Disorder Interview (MIDI) questions Prevalence: 26.6% |
Vaughan et al. (2013) [20] | 63 patients with Parkinson’s disease Female: 35% Mean (sd) age: 63 (9.7) years | IPSS Cut-off: ≥2 voids/nights Prevalence: 61% | MMSE Mean (sd) MMSE score: 28.6 (1.5) in patients without nocturia and 28.5 (1.9) in patients without Prevalence: NR |
Galizia et al. (2012) [21] | 1288 community-dwelling individuals Female: 57% Mean (sd) age: 74.2 (6.3) years | History taking Cut-off: ≥2 voids/nights Prevalence: 45.8% | MMSE Mean (sd) MMSE score: 25.3 (4.8) Prevalence: NR |
Lee et al. (2012) [22] | 299 community-dwelling men Mean (sd) age: 71.2 (5.0) years | History taking Cut-off: ≥2 voids/nights Prevalence: 56.0% | MMSE Mean (sd) MMSE score: 25.6 (3.4) Prevalence: NR |
Burgio et al. (2010) [23] | 1000 Medicare beneficiaries Female: 50% Mean (sd) age: 73.8 (NR) years | History taking Cut-off: ≥2 voids/nights Prevalence: 58.5% | MMSE Mean (sd) MMSE score: 25 (4.9) Prevalence (MMSE < 24): 29.8% |
Study | Univariate analysis | Multivariable analysis |
---|---|---|
Dutoglu et al. (2019) [17] | Lower MMSE scores in patients with ≥2 nocturia episodes compared to those with < 2 episodes; MCID observed only for the group with at least 4 nocturnal voids compared to the group with 1 nocturnal void No difference in dementia prevalence | Not performed |
Jung et al. (2017) [11] | No significant correlation between nocturia and MMSE Significant correlation between nocturia and CDR scale: r = 0.23; MCID: not assessable | Not performed |
Zhang et al. (2016) [18] | Significant difference of nocturia prevalence in patients with cognitive dysfunction vs. without 56.3% vs. 36.8%. Mean (sd) NMSS nocturia sub-score significantly higher in patients with cognitive dysfunction vs. without 2.9 (3.4) vs. 1.7 (3.0); MCID: not assessable | Urinary disorders (including nocturia) as a significant risk factor for cognitive dysfunctiona: OR 1.7, 95% CI [1.1–2.8] |
Scullin et al. (2013) [19] | No significant difference in Mean (sd) nocturia frequency score in patients with impulsivity vs. without impulsivity | - |
Vaughan et al. (2013) [20] | No significant difference in MMSE score in patients with nocturia vs. without nocturia | - |
Galizia et al. (2012) [21] | Mean (sd) MMSE score significantly lower in subjects with vs. without nocturia in univariate analysis: 25.0 (5.2) vs. 25.6 (4.4); MCID not reached | Not performed |
Lee et al. (2012) [22] | Mean (sd) MMSE score significantly lower in subjects with vs. without nocturia in univariate analysis: 24.4(4.0) vs. 25.9(3.4); MCID reached | Higher MMSE protective factor of nocturiab: OR 0.6 95%CI [0.5–0.9] |
Burgio et al. (2010) [23] | MMSE protective factor of nocturia with OR 0.9 (CI non available) MCID not assessable | Non-significant associationc,d |